New injection aims to clear hepatitis b virus in patients
NCT ID NCT07179653
Summary
This study is testing whether a new injection called TVAX-008 can help clear the hepatitis B virus from the body. It will involve 48 adults with chronic hepatitis B who have already been treated with certain drugs or are new to treatment. The main goal is to see if the injection safely removes the hepatitis B surface antigen, a key marker of infection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HBV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
NanFang Hospital
Guangzhou, Guangdong, 20000, China
Conditions
Explore the condition pages connected to this study.